Yakov Kogan
Gründer bei STATERA BIOPHARMA, INC.
Profil
Yakov Kogan was the founder of Cleveland BioLabs, Inc. (founded in 2003) where he held the title of Chief Executive & Financial Officer, Secretary from 2017 to 2019.
He is also the founder of Statera Biopharma, Inc. (founded in 2003) where he currently holds the title of Senior Vice President-Strategy & Alliance.
Dr. Kogan's current job(s) include being the Chief Executive Officer at Panacela Labs, Inc. since 2011, the Chief Operating Officer & Director at Quad M Solutions, Inc. since 2022, the Director & Principal Business Officer at Kadvax Technologies, Inc., and the Chief Operations Officer at Genome Protection, Inc.Dr. Kogan's former job(s) include being the Director-Business Development at Integrated Genomics, Inc. from 2002 to 2003, a Director at Incuron LLC, a Senior Scientist at ThermoGen, Inc., and a Research Associate at The University of Chicago.
Dr. Kogan's education history includes an MBA from The University of Chicago, a graduate degree from Moscow State University Lomonosov, and a doctorate degree from VNII Ekonomiki Selskogo Khozaystva.
Aktive Positionen von Yakov Kogan
| Unternehmen | Position | Beginn |
|---|---|---|
| STATERA BIOPHARMA, INC. | Gründer | 05.06.2003 |
| QUAD M SOLUTIONS, INC. | Geschäftsführer | 06.10.2022 |
Panacela Labs, Inc.
 Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Vorstandsvorsitzender | - |
Kadvax Technologies, Inc.
 Kadvax Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Kadvax Technologies, Inc. provides biotechnology research services. The private company is based in Houston. | Direktor/Vorstandsmitglied | - |
| Genome Protection, Inc. | Geschäftsführer | - |
Ehemalige bekannte Positionen von Yakov Kogan
| Unternehmen | Position | Ende |
|---|---|---|
| STATERA BIOPHARMA, INC. | Vorstandsvorsitzender | 13.12.2019 |
Integrated Genomics, Inc.
 Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Chicago-based Integrated Genomics™ specializes in research in microbial genomics, biochemistry, and gene expression. Its scientists has broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. Integrated Genomics™ has particularly long-standing relationships and active research in the area of lactic acid bacteria and pathogenic microbes, as well as a broad customer base across industry, academic and government institutions. Integrated Genomics™' products and services are based on ERGO™, its web-based genome analysis platform. ERGO™ integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO™ provides better and faster identification of gene function across all organisms. In 2010 Integrated Genomics, Inc.'s business operations were transitioned to a new corporation, IG Assets, Inc. With the original Integrated Genomics' team, IG Assets continues to provide the same ERGO-based microbial genomic products and service. | Corporate Officer/Principal | 01.01.2003 |
Incuron LLC
 Incuron LLC Pharmaceuticals: MajorHealth Technology Incuron LLC develops anticancer drugs. It provides an innovative pipeline of drugs to treat oncology and autoimmune disease for the global markets. The firm is a joint venture between Bioprocess Capital Ventures and Cleveland BioLabs. The company was founded in January 2010 and is headquartered in Moscow, Russia. | Direktor/Vorstandsmitglied | - |
| The University of Chicago | Corporate Officer/Principal | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Yakov Kogan
| The University of Chicago | Masters Business Admin |
| VNII Ekonomiki Selskogo Khozaystva | Doctorate Degree |
| Moscow State University Lomonosov | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| STATERA BIOPHARMA, INC. | Health Technology |
| QUAD M SOLUTIONS, INC. | Non-Energy Minerals |
| Private Unternehmen | 7 |
|---|---|
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
Integrated Genomics, Inc.
Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Chicago-based Integrated Genomics™ specializes in research in microbial genomics, biochemistry, and gene expression. Its scientists has broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. Integrated Genomics™ has particularly long-standing relationships and active research in the area of lactic acid bacteria and pathogenic microbes, as well as a broad customer base across industry, academic and government institutions. Integrated Genomics™' products and services are based on ERGO™, its web-based genome analysis platform. ERGO™ integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO™ provides better and faster identification of gene function across all organisms. In 2010 Integrated Genomics, Inc.'s business operations were transitioned to a new corporation, IG Assets, Inc. With the original Integrated Genomics' team, IG Assets continues to provide the same ERGO-based microbial genomic products and service. | Commercial Services |
ThermoGen, Inc.
 ThermoGen, Inc. Medical SpecialtiesHealth Technology ThermoGen, Inc. develops biocatalysts for pharmaceutical production. The company was headquartered in Chicago, IL. | Health Technology |
Incuron LLC
Incuron LLC Pharmaceuticals: MajorHealth Technology Incuron LLC develops anticancer drugs. It provides an innovative pipeline of drugs to treat oncology and autoimmune disease for the global markets. The firm is a joint venture between Bioprocess Capital Ventures and Cleveland BioLabs. The company was founded in January 2010 and is headquartered in Moscow, Russia. | Health Technology |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Health Technology |
Kadvax Technologies, Inc.
Kadvax Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Kadvax Technologies, Inc. provides biotechnology research services. The private company is based in Houston. | Commercial Services |
| Genome Protection, Inc. |
